Business Development Clinical Informatics Manufacturing Market Access Medical Devices and Diagnostics Pre-Clinical (Discovery and Development) Regulatory/Legal Pharma Logistics

Treating Asthma with Monoclonal Antibody Based Drugs: Past Experience and Future Prospects

Add bookmark
Tags: Matthew Catley asthma COPD respiratory pharmacology respiratory inflammatory disease monoclonal antibody based drugs monoclonal antibody mAbs chronic obstructive pulmonary disease antibody based therapies antibody generation

Recommended

FIND CONTENT BY TYPE

Reports News Articles Webinars Videos Glossary Infographics App

Pharma IQ COMMUNITY

Contact Us Advertise With Us User Agreement Cookie Policy About Us Become a Member Today Pharma IQ App

ADVERTISE WITH US

Advertise Now

JOIN THE Pharma IQ COMMUNITY

Join Pharma & Biotech today and interact with a vibrant network of professionals, keeping up to date with the industry by accessing our wealth of articles, videos, live conferences and more.

Pharma IQ, a division of IQPC

© 2025 All rights reserved. Use of this site constitutes acceptance of our User Agreement, Privacy Policy and Cookies Settings.

Careers With IQPC | Contact Us | About Us | Cookie Policy